Awilco Drilling PLC: Awilco Drilling Reports Q3 2021 results
Awilco Drilling PLC reports contract revenue of USD 7.4 million (USD 12.0 million Q2), EBITDA loss of USD 3.1 million (USD 3.0 million in Q2) and a net loss of USD 4.6 million, (USD 1.6 million in Q2).
Revenue efficiency was 97.4% during the quarter (96.7% in Q2).
Operational uptime was 99.9% during the quarter (94.2% in Q2).
Contract backlog at the end of Q3 was approximately USD 1.0 million (USD 7.1 million Q2).
Please see attached for the Q3 2021 report.
A digital presentation will be held on the same day, 16 November 2021, at 10:00 UK time (11:00pm CEST / 05:00 EDT). The presentation material will be available for download on the Investor Relations section (go to "Press Releases") at www.awilcodrilling.com prior to the meeting. There will be a Q&A session after the presentation.
To join the digital meeting, please click this link or copy and paste the following address into your browser:
A replay of the presentation will be made available on the Company website after the event.
Aberdeen, 16 November 2021
For further information please contact:
Eric Jacobs, Interim CEO
Phone: +44 1224 737900
Cathrine Haavind, IR Manager
Phone: +47 93 42 84 64
Email: ch@awilcodrilling.com
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Q3 2023/24 - First sale of the XM30 completed8.5.2024 18:20:00 CEST | Press release
ANNOUNCEMENT NO. 262 Trading statement for Q3 2023/24 (1 January - 31 March 2024) First sale of the XM30 completed Revenue declined by 6% in the third quarter of 2023/24 to DKK 98.9 million from DKK 105.4 million in the year-earlier period. The development reflected continued growth in sales of consumables and services, set off by declining sales of instruments as customers continued to show restraint in purchasing new instruments. EBITDA fell to DKK 43.1 million in the third quarter, being affected by higher staff costs, including non-recurring costs in connection with organisational changes. The EBITDA margin was 44%. In the third quarter, our two new products, the XcytoMatic 40 (XM40) and the XcytoMatic 30 (XM30) attracted satisfactory customer interest, and the first sale of the XM30 was completed. 2023/24Q3Q1-Q3Change, %Change, %Revenue, DKKm98.9-6298.2-14EBITDA, DKKm43.1-23136.2-32EBITDA margin (%)4446 Highlights Revenue declined by 6% in the third quarter of 2023/24 to DKK 98.9
3. kvartal 2023/24 - Første salg af XM30 er gennemført8.5.2024 18:20:00 CEST | pressemeddelelse
MEDDELELSE NR. 262 Periodemeddelelse for 3. kvartal 2023/24 (1. januar - 31. marts 2024) Første salg af XM30 er gennemført Omsætningen faldt i 3. kvartal med 6% til DKK 98,9 mio. mod DKK 105,4 mio. i samme periode sidste år. Udviklingen afspejler en fortsat fremgang i salget af forbrugsvarer og services, mens omsætningen af instrumenter har været faldende som følge af kundernes fortsatte tilbageholdenhed med at købe nye instrumenter. Resultatet af primær drift (EBITDA) faldt i 3. kvartal til DKK 43,1 mio. og var påvirket af øgede personaleomkostninger, herunder engangsomkostninger i forbindelse med organisationsændringer. EBITDA-marginen blev i 3. kvartal på 44%. I 3. kvartal har der været en tilfredsstillende interesse for de to nye produkter, XcytoMatic 40 (XM40) og XcytoMatic 30 (XM30), og det første salg af XM30 er gennemført. 2023/243. kvartal1.-3. kvartalÆndring, %Ændring, %Omsætning, DKK mio.98,9-6298,2-14EBITDA, DKK mio.43,1-23136,2-32EBITDA-margin, %4446 Hovedpunkter Omsætning
International Petroleum Corporation Announces 2024 Annual General Meeting Voting Results8.5.2024 18:00:00 CEST | Press release
International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce the voting results from the Corporation’s 2024 Annual General Meeting of Shareholders held on May 8, 2024 in Calgary, Alberta (the Meeting). Number of Directors The number of Directors of the Corporation was set at eight. Votes For% ForVotes Against% Against62,674,77899.995,3870.01 Election of Directors The eight nominees listed in the Corporation’s management information circular dated March 22, 2024 (the Circular) were elected as Directors of the Corporation to hold office until the next annual meeting of shareholders or until their successors are duly elected or appointed, unless the office is earlier vacated, as described in the Circular. NomineeVotes For% ForVotes Withheld% WithheldC. Ashley Heppenstall61,390,66198.101,187,5871.90William Lundin62,290,86899.54287,3800.46Chris Bruijnzeels62,177,25599.36400,9930.64Donald Charter55,737,08589.076,841,16310.93Lukas H. (Harry
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons8.5.2024 17:31:01 CEST | Press release
Bagsværd, Denmark, 8 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. Details of the person discharging managerial responsibilities/person closely associated a)Name of the Board member/Executive/Associated PersonMaziar Mike Doustdar2 Reason for the notificationa)Position/statusExecutive Vice Presidentb)Initial notification/AmendmentInitial notification3 Details of the issuera)NameNovo Nordisk A/Sb)LEI549300DAQ1CVT6CXN342
Treasury Bill Auction Announcement - RIKV 24 0717 - RIKV 24 11208.5.2024 17:31:00 CEST | Press release
SeriesRIKV 24 0717RIKV 24 1120ISINIS0000036267IS0000036366Maturity Date07/17/202411/20/2024Auction Date05/13/202405/13/2024Settlement Date05/15/202405/15/2024 On the Auction Date, between 10:30 am and 11:00 am, the Government Debt Management will auction Treasury bills in the Series, with the ISIN numbers and with the Maturity Dates according to the table above. Payments for the Treasury bills must be received by the Central Bank before 14:00 on the Settlement Date and the Bills will be delivered in electronic form on the same day. Further reference is made to the General Terms of Icelandic Treasury bills and General Terms of Auction for Treasury bills on the Government Debt Management website. For additional information please contact Magnús Freyr Hrafnsson, Government Debt Management, at +354 569 9679.